CHICAGO, Dec. 19, 2023 /PRNewswire/ -- MarketsandMarkets recently published a research report on Global MedTech Industry Outlook 2024. Despite the economic uncertainties and post-COVID slump in recent times, MedTech companies have demonstrated strong resilience throughout 2023. Overall, the market within the MedTech sector expanded by 4 - 5% during this period. Continued tech innovation, mergers, and acquisitions (M&A), commercialization of new product lines, and emergence of new business models are contributing to the sustained growth of the market.
The Global MedTech Industry Outlook for 2024 aims to provide insights into the anticipated performance of the MedTech sectors, covering recent advancements in imaging technologies and the development of innovative surgical solutions. The report will assess the industry's performance in 2023 relative to 2022 and highlight the significant breakthroughs and notable transformations in the MedTech landscape during 2023, with expectations of continued momentum into 2024.
Inquire Now: https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=64921163
The MedTech Industry Outlook 2024 is structured to provide:
- Analysis of factors, that influenced the performance and characteristics of the MedTech sector in 2023 as compared to 2022,
- Revenue estimations and growth rate projections for key sectors across MedTech between 2023 and 2024,
- Highlights of the key trends to watch out for in 2024,
- Recommendations and prioritized list of growth opportunities for 2024,
- Best practices and success stories that exemplify how market participants overcame challenges to build and deploy solutions using innovative business models.
- Act as the knowledge base for an interactive session with the industry experts at MarketsandMarkets.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=64921163
The MedTech Industry Outlook 2024 report is an insightful toolkit for incumbent market participants, tech players, SME's, the investment community as well as the long list of players who form part of the upstream supply chain in this sector.
Some of the key developments witnessed by the MedTech industry in 2023:
- Dawn of ambulatory care facilities across the mature markets coupled with an uptick in ambulatory surgical volumes particularly driven by cardiology, vascular, and orthopedics.
- For example, Surgery Partners (US) collaborated with Intermountain Health (US) Methodist Health System (US) to expand outpatient surgical services in the country.
- MedTech firms are strategically aligning for customer success.
- In 2023, Terumo and Siemens Healthineers India have formed a partnership to enhance cardiac care in India. This collaboration involves joint efforts in areas such as physician training and development, accessibility to advanced medical technologies, and increased reach in Tier 2 and 3 cities.
- AI/ML-powered tech revolution is driving the value-based care model while assisting the provider facilities with more precise and personalized patient care.
MedTech Industry Future Growth Anchored in Precision Medicine.
2024 is expected to be a transformative year in MedTech propelled by precision medicine in a pivotal role, worldwide. This trend will be driven by the convergence of genomic datasets, innovative molecular & imaging technologies coupled with advanced data analytics algorithms. This evolution is particularly evident through individualized patient care based on genetic, molecular, and lifestyle factors. For instance, existing cancer management approaches are getting disrupted with tailored approaches developed based on patients' unique genetic mutations. Through genomic sequencing, clinicians are utilizing more targeted therapies for cancer (such as Theranostics), thereby maximizing clinical effectiveness with lower side effects. Further, integrating AI and ML algorithms is expected to refine patient diagnostics further to result in a significantly higher accuracy with early disease detection capabilities.
The global Precision medicine market is anticipated to grow at >11% Y-o-Y during 2023 - 24, reaching a market value of USD 29.1 billion. Various factors fueling this growth trajectory include a strong focus of MedTech giants on related product development (For example, GE & Philips focus on theranostics), supportive regulatory guidelines to actively deploy related modalities globally, and greater availability of patient data through wearables and digital health apps. Therefore, overall, the strategic outlook in 2024 is anticipated to observe a paradigm shift toward a more effective, personalized, and patient centric healthcare model that will result in reduced healthcare costs and higher margins for caregivers.
Some of the other key trends that the MedTech industry is likely to witness in 2024:
Artificial Intelligence (AI) is making significant contributions to various aspects of MedTech, enhancing diagnostics, patient screening, personalized medicine, and therapeutic modalities. According to recent data, over half of the global healthcare organizations intend to deploy AI plans and widely utilize the technology by 2025. Below are most anticipated growth areas to look out for in 2024:
- AI In radiology is emerging as "2nd opinion expert" within hospitals and diagnostic centers, with GE, Philips, and Siemens expected to be the front runners.
- Remote patient monitoring space to garner higher investor confidence in 2024: Mainly driven by higher patient adoption, greater reimbursements, and increasingly supportive govt policies.
- Augmented reality (AR) becomes extended reality (XR): AR/VR moving beyond immersive experience and moving towards key disease areas. Non-Healthcare companies such as Meta, Google, and Apple are front runners in 2024, along with traditional med-tech companies like Stryker (Mako).
- ESG becomes a foundation of MedTech strategy, shaping responsible innovation and patient-centered focus as well as institutional KPI's.
Request FREE Sample Pages Now: https://www.marketsandmarkets.com/requestsampleNew.asp?id=64921163
Key MedTech Industry Market Players
The prominent MedTech players include Abbott (US), Becton Dickinson (US), Boston Scientific Corporation (US), Cardinal Health (US), Fresenius Medical Care (Germany), Fujifilm Corporation (Japan), GE Healthcare (US), Johnson & Johnson (Japan), Medtronic (Ireland), Philips Healthcare (Netherlands), Roche (Switzerland), Samsung Medical (South Korea), Siemens Healthineers (Germany), and Stryker Corporation (US), among others.
In 2023, industry leaders strived to maintain their competitive leadership positions with product launches, technological advancements, regulatory approvals, and strategic deals. In 2024, key players will continue investments in research and development (R&D), product differentiation in imaging and surgical applications, greater portability of medical devices, and focus on AI-based unique offerings.
Related Reports:
The Global Biotechnology Outlook 2024
About MarketsandMarkets:
MarketsandMarkets has been recognized as one of America's best management consulting firms by Forbes, as per their recent report.
MarketsandMarkets is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients.
Earlier this year, we made a formal transformation into one of America's best management consulting firms as per a survey conducted by Forbes.
The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are substituting existing revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines - TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the 'GIVE Growth' principle, we work with several Forbes Global 2000 B2B companies - helping them stay relevant in a disruptive ecosystem. Our insights and strategies are molded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research. The KnowledgeStore (our Market Intelligence Cloud) integrates our research, facilitates an analysis of interconnections through a set of applications, helping clients look at the entire ecosystem and understand the revenue shifts happening in their industry.
To find out more, visit www.MarketsandMarkets.com or follow us on Twitter, LinkedIn and Facebook.
Contact:
Mr. Aashish Mehra
MarketsandMarkets INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com/
Content Source: https://www.marketsandmarkets.com/PressReleases/global-medtech-industry-outlook.asp
Logo: https://mma.prnewswire.com/media/2297424/MarketsandMarkets_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/global-medtech-industry-outlook-2024--exclusive-report-by-marketsandmarkets-302018882.html
